Compare Domino's Pizza, Inc. (DPZ) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs Zoetis Inc — how do they compare? Domino's Pizza, Inc. trades at $309.23 (market cap $10.21B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 3× Domino's Pizza, Inc.'s market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Zoetis Inc for 70 Days on average.
| DPZ | ZTS | |
|---|---|---|
Market Cap | $10.21B | $30.20B |
Volume | 916,737 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $147.53 |
52-Week Low | $282.89 | $69.09 |
Typical Hold Time | 106 Days | 70 Days |
Enterprise Value | $15.17B | $37.76B |
Dividend Yield | 2.58% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DPZ trades at $309.36, up 2.07% today, amid a mixed technical and fundamental backdrop. The stock shows a bullish overall technical signal but has missed earnings estimates for three consecutive quarters. Revenue and net income have grown steadily, reaching $4.94 billion and $601.70 million in 2025, respectively, though profit margins are under slight pressure. Recent news highlights store closures and dividend stability concerns alongside promotional initiatives.
The outlook is cautiously optimistic, supported by analyst consensus but tempered by high debt and recent earnings misses. Investment opportunity lies in potential valuation expansion toward the $373 price target, while key risks include elevated leverage, competitive pressures, and execution challenges in maintaining growth.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
